Scientists have found the genetic differences linked with increased risk of developing a disease (which been termed) hypertriglyceridemia (HTG) and is supposedly a risk for most of the cardio patients.

HTG is linked with obesity, diabetes and pancreatitis. It has also been stated that the thorough understanding of genes make patients susceptible to HTG thus providing evidence for better treatment measures.

At the Robarts Research Institute, Schulich and at School of Medicine & Dentistry in The University of Western Ontario done by Dr. Robert Hegele and his team has revealed that an amalgamation of both common and rare variants or "misprints" present in several genes join up to put a patient at risk of developing HTG.

It is considered as an obvious thing as any single gene is not responsible for high triglyceride levels but offers a mixture of both common and rare variations in several genes, as reported by Nature.

Further elucidation of the report throws light on patient's genetic risk, who can be made in charge for both common and rare variants as in case of many genes at the same instant making it an offering to diagnose both types of variation.